Sassicaia Capital Advisers LLC

Add to watchlist

$2.13 Million is the total value of Sassicaia Capital Advisers LLC's 6 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was - .

All

			Value		Shares		↓ Weighting
	New	SOLENO THERAPEUTICS INC	$255,409	–	8,655	+100.0%	12.02%	–
PFE	New	PFIZER INC	$248,775	–	7,500	+100.0%	11.70%	–
FEMY	New	FEMASYS INC	$214,354	–	71,931	+100.0%	10.08%	–
EZGO	New	EZGO TECHNOLOGIES LTD	$1,426	–	10,000	+100.0%	0.07%	–

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR filed 2023-11-14

Signatures

The EDGAR filing(s) were signed by:

John Thurber — Chief Compliance Officer

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
SPDR S&P 500 ETF TR	10	Q2 2023	31.3%
INVESCO QQQ TR	10	Q2 2023	20.4%
NVIDIA CORPORATION	10	Q3 2023	24.0%
AMAZON COM INC	10	Q2 2023	14.8%
TESLA INC	9	Q3 2023	51.8%
APPLE INC	7	Q2 2023	39.6%
ADVANCED MICRO DEVICES INC	7	Q2 2023	5.5%
MUSTANG BIO INC	7	Q4 2022	0.3%
SPDR DOW JONES INDL AVERAGE	6	Q1 2023	3.7%
MICROSOFT CORP	5	Q2 2023	23.2%

View Sassicaia Capital Advisers LLC's complete holdings history.

Latest significant ownerships (13-D/G)

Sassicaia Capital Advisers LLC Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
BIO-PATH HOLDINGS INC^{Sold out}	February 14, 2020	0	0.0%
PLUS THERAPEUTICS, INC.	February 14, 2020	3,798	0.1%

View Sassicaia Capital Advisers LLC's complete significant-ownership history.

Latest filings

Type	Filed
13F-HR	2024-02-14
13F-HR	2023-11-14
13F-HR	2023-08-14
13F-HR	2023-05-15
13F-HR	2023-02-14
13F-HR	2022-11-14
13F-HR	2022-08-15
13F-HR	2022-05-13
13F-HR	2022-02-14
13F-HR	2021-11-15

View Sassicaia Capital Advisers LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Export Sassicaia Capital Advisers LLC's holdings